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Summary Twenty cervical carcinomas were examined for loss of heterozygosity (LOH) using 22 (Knudson, 1989) . The location of candidate tumour suppressor genes can be identified by restriction fragment length polymorphism (RFLP) analysis.
A number of putAtive tumour suppressor genes have now been identified (Ponder, 1988; Sager, 1989) , and include the prototype retinoblastoma tumour suppressor gene located at 13q.14; two possible Wilms' tumour Knudson's 'two-hit' hypothesis of carcinogenesis (Knudson, 1989) (Mackay et al., 1988a; Sato et al., 1991) , colon (5q, 17p, 18q) (Vogelstein et al., 1988; Fearon et al., 1990; Ashton-Rickardt et al., 1991; Purdie et al., 1991) , ovary (17p, 17q) (Eccles et al., 1990; Russell et al., 1990) , lung (3p, 5q) (Naylor et al., 1987; Mori et al., 1989; Ashton-Rickardt et al., 1991) , kidney (3p) (Zbar et al., 1987) , bladder (9q, 1 lp, 17p) (Tsai et al., 1990 ), brain (17p) (Fults et al., 1989) , and bone (13q, 17p) (Toguchida et al., 1988; .
In cervical carcinoma, reports of cytogenetic data are few and the numbers of tumours studied have been relatively small. In general, the chromosomal picture has been extremely variable and complex, with complete karyotyping accomplished in only a few cases. Triploidy and tetraploidy are not uncommon, but no single cytogenetic abnormality has been consistently associated with this tumour type. As in many other types of neoplasia, chromosome 1 has been found to be involved in a non-random fashion, with aberrations comprising both numerical changes and structural rearrangements (Atkin & Baker, 1979; 1982; 1984) . These aberrations which include isochromosomes, deletions, duplication, and associated translocations of both the long and short arms, have also been associated with other chromosomes, including chromosomes 3, 4 or 5, 6, 11, 13, 17, 18 and 21 (Atkin & Baker, 1979; 1982; 1984) . It has been suggested that chromosome 17 derived markers, frequently present in carcinoma of the cervix, may signify the importance of genes on this chromosome. It has further been postulated that their importance to the development of this cancer may lie in the loss of recessive genes on chromosome 17p (Atkin & Baker, 1989) . Furthermore, loss of heterozygosity in primary cervical carcinomas has been reported on chromosomes 3 (Yokota et al., 1989) , 11 (Riou et al., 1988; Srivatsan et al., 1991) , and 17 (Kaelbling et al., 1992 Three major cervical carcinoma types -squamous carcinoma, adenocarcinoma and adenosquamous carcinoma -of various grades and stages were represented (Table II) , and patients' ages ranged from 23-70 years.
Tumour tissue was snap frozen in liquid nitrogen immediately after surgical removal, and stored at -70°C until DNA extraction. The presence of tumour tissue was confirmed by microscopy. Macroscopic non-cancerous tissue was trimmed from the specimen before DNA extraction, and specimens with less than 70% carcinoma on frozen section were discarded.
Ten jLg samples of high molecular weight DNA, extracted from peripheral blood lymphocytes and homogenised fresh tumour tissue, were digested with appropriate restriction endonucleases (Table I) , size fractionated by electrophoresis on 0.8% agarose gels, and transferred to Hybond N nylon membranes by Southern blotting.
Polymorphic DNA probes (Table I) were used to compare tumour and constitutional genotypes. Probes were radiolabelled with 32P-dCTP by a standard random multiprime method (Amersham). Prehybridisation and hybridisation were performed for 2 and 16 h respectively at 65°C using the same buffer (2.5 x Denhardts, 0.1% SDS, 0.1% NaPPi, 5 x SSC, 0.01% denatured salmon sperm DNA). Filters were washed at 65°C (4 x 15 min/0.1 x SSC, 0.1% SDS), autoradiographed at -70°C (Kodak XAR-5 film/Dupont Lightning-Plus Intensifying screens), and the autoradiographs interpreted after 1-14 days.
Primers specific for regions of the E6 gene of HPV types 6, 11, 16, 18 and 33, (Arends et al., 1991) were used in polymerase chain reactions (PCR), with 500ng samples of tumour DNA as template using 0.5 1fl Taq polymerase (Northumbria Biologicals Ltd.) in a volume of 100 l per reaction. Thirty-two to 35 cycles of annealing (50/55°C) (2 min), extension (/20C) (3 min) and denaturation (94°C) (1 min) were preceded by an initial 1.5 min denaturation step and ended with a 10 min extension. The annealing temperature was optimised for, and therefore varied with each HPV type (HPV 6 and 16 -55°C; HPV 11, 18 and 33 -50°C).
PCR products were size fractionated by electrophoresis on 3% agarose gels containing ethidium bromide, and the 
Linearised HPV plasmid DNA was radiolabelled and used as a probe in hybridisation experiments with Southern blots of DNA from HPV-positive tumours. Band sizes on the resultant autoradiographs were compared with that of the linearised plasmid HPV DNA, and indicated whether the viral DNA present in the tumour was episomal or integrated.
Results
The results of 211 RFLP analyses of constitutional and tumour DNA samples from 20 patients with cervical carcinoma at 22 polymorphic loci are given in Table I . For each of the 22 marker loci on eight autosomal chromosomal arms, at least two and up to 15 cases were informative. In general, a low overall incidence of LOH was reflected at each oncosuppressor site tested.
Fifteen of the 22 markers revealed LOH in one or more of the informative cases. The frequency of LOH amongst informative cases (Table I ) ranged from 7% (pEJ6.6 and PTH) to 30% (Calcitonin). An incidence of 50% LOH occurred with only one probe, pL5.62, in which one of only two informative cases showed LOH. However, over the whole series, of 211 informative loci, only 22 sites (10%), distributed amongst nine tumours, showed LOH.
The majority (11) of the 20 tumours showed no losses at any tested site, and 12 of the examples of LOH were found in just two of the 20 tumours. Clinically and histologically, these two tumours (both squamous carcinomas) did not appear to differ from the others.
Addressing specific chromosomal sites in turn, the combined result with six RFLP markers on chromosome 17p detected LOH at one or more loci in only three of 20 informative cases. All the LOH observed was compatible with deletion involving the p53 gene in the vicinity of 17p.13. No losses were observed amongst 13 informative cases on 17q using the VNTR probe THH59.
No losses were identified amongst 14 informative cases at the locus defined by p68RS2.0 within the Rb gene on chromosome 13q. On chromosome llp, the calcitonin locus, the c-Ha-ras-1 locus defined by marker pEJ, and those defined by markers PTH and FSH P were analysed. Five losses occurred amongst 19 informative cases. Three cases exhibited LOH at the calcitonin locus; one loss was observed at loci defined by each of the markers pEJ and PTH; and no losses were seen in four cases informative with FSH P. We observed only one LOH amongst four informative cases using the probe pEFD145 which recognises a sequence within the chromosome 3p.21 band.
Two markers were used to detect losses on the long arm of chromosome 18 -pBV1 5.65 and SAM 1.1. Of 12 informative cases, three showed losses -two cases at the SAM 1.1 locus and the other at both loci.
Lastly, one loss was observed in seven informative cases (14%) at the locus defined by marker TL1I on chromosome 8q -so far not implicated as an oncosuppressor site, and hence useful as a 'control' site. (Table III) . Although only a limited subset of chromosomal regions was examined, the results suggest that these oncosuppressor genes, commonly implicated in other human tumours, do not play a significant role in cervical carcinogenesis. Allele deletions on chromosome 17p have been reported in up to 61% of breast carcinomas (Mackay et al., 1988a) ; 73.1% of osteosarcomas (Toguchida et al., 1989) ; 75% of colonic carcinomas (Vogelstein et al., 1988) ; 50-60% of epithelial ovarian carcinomas (Eccles et al., 1990; Russell et al., 1990) ; up to 55% of brain tumours (Fults et al., 1989) and 63% of bladder carcinomas (Tsai et al., 1990 ) -suggesting the presence of a tumour suppressor gene that is involved in a carcinogenetic mechanism common to all of these tumours. Our data show only 15% of informative tumours with 17p allele loss; a similar proportion to that identified in a recently published series of cervical carcinomas (Kaelbling et al., 1992) , but a significantly lower proportion (P <0.05; Fisher's Exact Test) than that observed using similar probes in tumours of breast, bladder, ovary, bone, and colon. This may imply that any association between 17p allele loss and carcinogenesis does not extend to cervical carcinoma.
An association between the HPV E6 and E7 genes and the p53 (17p) and Rb (13q) genes respectively, has been suggested (Banks et al., 1990; Crook et al., 1991; Scheffner et al., 1991) . Inactivated p53 protein has been associated with HPV 16 E6 oncoprotein complex formation (Scheffner et al., 1991) while the Rb gene cellular protein has been associated with HPV 16 E7 protein (Banks et al., 1990; Scheffner et al., 1991) . In studies on cervical carcinoma cell lines, and more recently on cervical tumour tissue, wild type p53 mRNA and DNA were sequenced from HPV positive cell lines and tumours respectively, while the mutated form was detected only in those that were HPV negative; suggesting that alternative and mutually exclusive routes for altering p53 function are adopted in cervical carcinogenesis: mutation, or complex formation with HPV E6 (Crook et al., 1991; (Saxon et al., 1986) ; and a putative tumour suppressor gene identified in HeLa cells has been mapped to the chromosome llq.13 region (Srivatsan et al., 1991) . Loss of heterozygosity on chromosome 11, in 30% of cervical carcinoma cases, has been reported in a recent study (Srivatsan et al., 1991) ; while 36% LOH on chromosome lp had been reported in a previous series (Riou et al., 1988) . Our analysis using four markers on the short arm of chromosome 11 revealed a frequency of LOH lower than that observed with equivalent probes in breast cancer; and, for three of the four probes used, the incidence of LOH was distinctly lower than that observed at the 'innocent' locus on 8q. It therefore appears unlikely that an oncosuppressor gene of major importance to cervical carcinogenesis resides on the short arm of chromosome 11. An analysis of the long arm of this chromosome Lung (Naylor et al., 1987) 9/9 100 1/4 25 0.014
Kidney (Zbar et al., 1987) 11/11 100 1/4 25 0.009 18q
Colon (Fearon et al., 1990) was not performed because of the unavailability of DNA probes.
Similarly, losses on chromosome 5q in the region of the APC and MCC tumour suppressor genes, and on 18q in the vicinity of the DCC gene have been associated with colorectal cancer at levels of 41.5% (Ashton-Rickardt et al., 1991) , and 71.0% (Fearon et al., 1990) respectively, but, a high level of LOH was not detected at these loci in cervical carcinoma.
Previously published work in this field reported the occurrence of allele losses in nine of nine informative cases on chromosome 3 at p14-21 (Yokota et al., 1989) . Although our results do not directly refute this finding, as the probe used by Yokota et al., was not available to us, we demonstrated no significant LOH at a locus just bordering this region (3p.21).
Human papilloma viruses, especially types 16 and 18, have long been associated with malignancy in the cervix (Bosch et al., 1989; zur Hausen, 1989; Chang, 1990; Singer & Jenkins, 1991) . This association has been confirmed by PCR in 75% of the cases in the present study. However, our finding that common HPV types 6, 11, 16, 18 and 33 were absent in 25% of the tumours examined suggests that HPV infection may not be a prerequisite for malignant transformation in the cervix. Both HPV-positive and HPV-negative tumours showed a low frequency of LOH, and there was no consistent relationship between LOH and the integrated or 
